Understand the source comparison
Best DSIP Dosage for Sleep Quality: Dosage and Protocol Comparison
1mg SC 30–60 min pre-sleep Mild delta wave improvement (10–15% vs baseline) in controlled trials Minimal. Sustainable long-term Ideal starting dose for titration; establishes baseline response without tolerance risk 1.5–2mg SC Moderate delta wave improvement (
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- 1mg SC
- 30–60 min pre-sleep
- Mild delta wave improvement (10–15% vs baseline) in controlled trials
- Minimal. Sustainable long-term
- Ideal starting dose for titration; establishes baseline response without tolerance risk
- 1.5–2mg SC
- Moderate delta wave improvement (18–25% vs baseline), reduced sleep latency
- Low if cycled 4–5 nights/week
- Therapeutic range for most research subjects; balances efficacy and receptor preservation
- 2.5–3mg SC
- Peak delta wave improvement (25–31% vs baseline) in responsive individuals
- Moderate if used nightly beyond 3 weeks
- Ceiling dose for most protocols; exceeding this rarely adds benefit and accelerates tolerance
- 4–5mg SC
- Statistically insignificant improvement over 2.5–3mg in most trials
- High. Receptor desensitisation within 2–3 weeks of nightly use
- Not recommended without prior titration; increases tolerance risk without proportional benefit
- >5mg SC
- Any timing
- No additional therapeutic benefit documented in peer-reviewed trials
- Very high. Tolerance develops rapidly
- Outside therapeutic window; degrades cost-effectiveness and long-term viability